SAO PAULO, Feb. 25 (Xinhua) -- The CoronaVac vaccine, developed by Chinese company Biotech Ltd., has already been used in Brazil for over a month now and has been widely praised by Brazilian experts, who generally consider it to be safe, effective and helpful for Brazil to mitigate and overcome the COVID-19 pandemic.
On January 7 this year, the Brazilian federal government announced that it has signed a deal with the Butantan Institute to acquire 100 million doses of CoronaVac.
On January 17, the Brazilian Health Regulatory Agency authorized the emergency use of CoronaVac. Several people in Sao Paulo state were vaccinated with CoronaVac the same day to become first ones in Brazil to be vaccinated against COVID-19.
On January 18, doses of CoronaVac were distributed to other states from Sao Paulo state, initiating the mass vaccination in Brazil.
Produced by Xinhua Global Service
